Table 2.
Arithmetic means of PCB and PBDE congeners (ng/g lipid) and detection rate of congeners in each group
Congeners | Pre-eclampsia(n = 45) | Control (n = 70) | P-value* | ||
---|---|---|---|---|---|
Detection rate | Mean ± SD | Detection rate | Mean ± SD | ||
PCB28 | 33 (73.33) | 0.03 ± 0.02 | 40 (57.14) | 0.01 ± 0.01 | <0.001 |
PCB52 | 17 (37.78) | 0.014 ± 0.014 | 18 (25.71) | 0.010 ± 0.014 | 0.37 |
PCB99 | 26 (57.78) | 0.02 ± 0.01 | 29 (41.43) | 0.01 ± 0.01 | 0.06 |
PCB101 | 18 (40) | 0.01 ± 0.01 | 14 (20) | 0.008 ± 0.007 | 0.05 |
PCB118 | 42 (93.33) | 0.04 ± 0.02 | 51 (72.86) | 0.02 ± 0.01 | <0.001 |
PCB138 | 45 (100) | 1.51 ± 1.03 | 70 (100) | 0.81 ± 0.66 | <0.001 |
PCB153 | 45 (100) | 1.84 ± 1.25 | 70 (100) | 1.13 ± 1.02 | <0.001 |
PCB180 | 44 (97.78) | 0.19 ± 0.17 | 45 (64.29) | 0.05 ± 0.05 | <0.001 |
PCB187 | 38 (84.44) | 0.07 ± 0.07 | 24 (34.29) | 0.02 ± 0.03 | <0.001 |
PBDE28 | 35 (77.78) | 0.05 ± 0.06 | 14 (20) | 0.01 ± 0.01 | <0.001 |
PBDE47 | 38 (84.44) | 0.10 ± 0.12 | 36 (51.43) | 0.05 ± 0.07 | 0.001 |
PBDE99 | 39 (86.67) | 0.06 ± 0.07 | 25 (35.71) | 0.02 ± 0.03 | <0.001 |
PBDE100 | 10 (22.22) | 0.01 ± 0.008 | 8 (11.43) | 0.01 ± 0.004 | 0.71 |
PBDE153 | 45 (100) | 1.88 ± 1.52 | 70 (100) | 1.07 ± 0.83 | 0.001 |
PBDE154 | 6 (13.33) | 0.01 ± 0.007 | 4 (0.54) | 0.01 ± 0.003 | 0.35 |
PBDE183 | 24 (53.33) | 0.03 ± 0.03 | 24 (34.29) | 0.02 ± 0.02 | 0.13 |
PBDE209 | 7 (15.56) | 0.01 ± 0.006 | 14 (20) | 0.01 ± 0.007 | 0.86 |
Date shown as mean ± SD and numbers with percentages in parenthesis
*P-value refers to comparison of means by Mann–Whitney U-test between congener’s concentrations. Significant P-value was bolded